Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5827377 | European Journal of Pharmacology | 2015 | 31 Pages |
Abstract
Nicotinic acetylcholine receptors (nAChRs) seem to play an integral role in the progress and/or prevention of Alzheimer׳s diseases (AD). Functional abnormalities and problems in biogenesis and trafficking of nAChRs are two major culprits in AD; on the other hand, chaperones modulate post-translational changes in nAChRs. Moreover, they indirectly regulate nAChRs by controlling AD-related proteins such as tau and amyloid beta (Aβ). In this review, we go through recent studies which are showing that chaperones modulate the expression of nAChRs in a subtype-specific manner and explain how AD progress is affected by nAChRs chaperoning.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Saeed Sadigh-Eteghad, Alireza Majdi, Mahnaz Talebi, Javad Mahmoudi, Shirin Babri,